Travaux scientifiques

Prof. Dr. Nilüfer Avcı

38 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. A1. Avci N, Cecener G, Deligonul A, Erturk E, Tunca B, Egeli U, Tezcan G, Akyildiz EU, Bayram AS, Gebitekin C, Kurt E, Evrensel T. Molecular markers for patients with thymic malignancies: not feasible at present? Asian Pac J Cancer Prev. 2014;15(8):3457-60. PubMed PMID: 24870739.

    Source : page de profil sur medicana.com.tr

  2. A2. Ulas A, Kos T, Avci N, Cubukcu E, Olmez OF, Bulut N, Degirmenci M. Patients with HER2-positive Early Breast Cancer Receiving Adjuvant Trastuzumab: Clinicopathological Features, Efficacy, and Factors Affecting Survival. Asian Pac J Cancer Prev. 2015;16(4):1643-9. PubMed PMID: 25743846.

    Source : page de profil sur medicana.com.tr

  3. A3. Kanat O, Cubukcu E, Avci N, Budak F, Ercan I, Canhoroz M, Olmez F. Comparison of three different treatment modalities in the management of cancer cachexia. Tumori. 2013 Mar-Apr;99(2):229-33. doi: 10.1700/1283.14197. PubMed PMID: 23748819.

    Source : page de profil sur medicana.com.tr

  4. A4. Avci N, Deligonul A, Tolunay S, Cubukcu E, Fatih Olmez O, Ulas A, Hartavi M, Kurt E, Evrensel T. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer. J BUON. 2015 Jan-Mar;20(1):45-9. PubMed PMID: 25778295.

    Source : page de profil sur medicana.com.tr

  5. A5. Avci N, Deligonul A, Tolunay S, Cubukcu E, Olmez OF, Altmısdortoglu O, Tanrıverdi O, Kurt E, Evrensel T. Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy. J BUON. 2015 Jul-Aug;20(4):994-1000.

    Source : page de profil sur medicana.com.tr

  6. A6. Cubukcu E, Olmez OF, Avci N, Canhoroz M, Kurt E, Kanat O, Evrensel T, Manavoglu O. Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors. J BUON. 2012 Jul-Sep;17(3):517-21. PubMed PMID: 23033292.

    Source : page de profil sur medicana.com.tr

  7. A7. Ulas A, Turkoz FP, Silay K, Tokluoglu S, Avci N, Oksuzoglu B, Alkis N. A laboratory prognostic index model for patients with advanced non-small cell lung cancer. PLoS One. 2014 Dec 4;9(12):e114471. doi: 10.1371/journal.pone.0114471. PubMed PMID: 25474743; PMCID: PMC4256446.

    Source : page de profil sur medicana.com.tr

  8. A8. Ulas A, Silay K, Akinci S, Dede DS, Akinci MB, Sendur MA, Cubukcu E, Coskun HS, Degirmenci M, Utkan G, Ozdemir N, Isikdogan A, Buyukcelik A, Inanc M, Bilici A, Odabasi H, Cihan S, Avci N, Yalcin B. Medication Errors in Chemotherapy Preparation and Administration: a Survey Conducted among Oncology Nurses in Turkey. Asian Pac J Cancer Prev. 2015;16(5):1699-705. PubMed PMID: 25773812.

    Source : page de profil sur medicana.com.tr

  9. A9. Tanriverdi O, Cokmert S, Oktay E, Pilanci KN, Menekse S, Kocar M, Sen CA, Avci N, Akman T, Ordu C, Goksel G, Meydan N. Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy. Med Oncol. 2014 Oct;31(10):217. doi: 10.1007/s12032-014-0217-z. PubMed PMID: 25216865.

    Source : page de profil sur medicana.com.tr

  10. A10. Tanriverdi O, Yildirim B, Gul S, Cevik E, Akman T, Cokmert S, Pilanci KN, Avci N, Ordu C, Barutca S. Effect of lower extremity deep vein thrombosis on cancer recurrence in stage III colon cancer patients. Med Oncol. 2014 Oct;31(10):215. doi: 10.1007/s12032-014-0215-1. PubMed PMID: 25208817.

    Source : page de profil sur medicana.com.tr

  11. A11. Tanriverdi O et al. Clinical and pathological features of 133 colorectal cancer patients with brain metastasis: multicenter retrospective analysis. Med Oncol. 2014 Sep;31(9):152. doi: 10.1007/s12032-014-0152-z. PubMed PMID: 25108599.

    Source : page de profil sur medicana.com.tr

  12. A12. Yildiz I et al. Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: Turkish Oncology Group trial. Anticancer Res. 2014 Aug;34(8):4329-34. PubMed PMID: 25075067.

    Source : page de profil sur medicana.com.tr

  13. A13. Canhoroz M et al. Clinical significance of adiponectin expression in colon cancer patients. J Cancer Res Ther. 2014 Apr-Jun;10(2):347-53. doi: 10.4103/0973-1482.136634.

    Source : page de profil sur medicana.com.tr

  14. A14. Cecener G et al. BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients. Cancer Invest. 2014 Oct;32(8):375-87. doi: 10.3109/07357907.2014.919302.

    Source : page de profil sur medicana.com.tr

  15. A15. Cubukcu E et al. Lack of prognostic significance of adiponectin expression in triple-negative breast cancer. Contemp Oncol (Pozn). 2014;18(1):34-8. doi: 10.5114/wo.2014.40454.

    Source : page de profil sur medicana.com.tr

  16. A16. Hartavi M et al. The SOCS-1 -1478CA/del polymorphism is not associated with colorectal cancer in Turkish subjects. Asian Pac J Cancer Prev. 2013;14(12):7583-6.

    Source : page de profil sur medicana.com.tr

  17. A17. Uyeturk U et al. Risk factors for stage IV breast cancer at presentation in Turkey. Asian Pac J Cancer Prev. 2013;14(12):7445-9.

    Source : page de profil sur medicana.com.tr

  18. A18. Olmez OF et al. Prognostic significance of HER-3 expression in metastatic breast cancer. Asian Pac J Cancer Prev. 2013;14(7):4115-9.

    Source : page de profil sur medicana.com.tr

  19. A19. Cubukcu E et al. Prognostic significance of ER, PR, HER2/neu, Ki-67, and nm23 expression in invasive breast cancer. J BUON. 2013 Apr-Jun;18(2):359-65.

    Source : page de profil sur medicana.com.tr

  20. A20. Olmez OF et al. c-Met expression as independent predictor of survival in glioblastoma multiforme. Clin Transl Oncol. 2014 Feb;16(2):173-7.

    Source : page de profil sur medicana.com.tr

  21. A21. Kurt E et al. Evaluation of carboplatin plus docetaxel regimen in elderly advanced gastric cancer patients. J BUON. 2013 Jan-Mar;18(1):147-53.

    Source : page de profil sur medicana.com.tr

  22. A22. Olcun Umit Unal et al. Clinicopathologic characteristics and prognostic factors of primary thoracic soft tissue sarcoma. Thoracic Cancer. 2015;6(1):85–90. doi: 10.1111/1759-7714.12150.

    Source : page de profil sur medicana.com.tr

  23. A23. Kocak N et al. Effects of 1alpha,25-dihydroxyvitamin D3 on doxorubicin-induced chromosomal aberrations. Acta Oncol. 2004;43(2):204-8.

    Source : page de profil sur medicana.com.tr

  24. A24. Akman T et al. A View from Young Oncologists on Clinical Trials in Turkey: Obstacles and Solutions. UHOD 2014;3(24):1-7.

    Source : page de profil sur medicana.com.tr

  25. A25. Nilüfer Avcı et al. General Characteristics of Male Breast Cancer Patients in Bursa Region. J Breast Health. 2012;8(3):126-129.

    Source : page de profil sur medicana.com.tr

  26. A26. Nilüfer Avcı et al. Prevalence of Herbal Product Use as Alternative Medicine Among Cancer Patients in Turkey. J Clin Anal Med. 2015;6(3):327-30.

    Source : page de profil sur medicana.com.tr

  27. A27. Nilüfer Avcı et al. Metaplastic Breast Cancer and EGFR Expression. J Clin Anal Med. 2015;6(5):616-9.

    Source : page de profil sur medicana.com.tr

  28. A28. Çubukçu S et al. Efficacy of Sunitinib in Imatinib Resistant GIST Patients. J Clin Anal Med. 2014;5(4):304-6.

    Source : page de profil sur medicana.com.tr

  29. A29. Ordu Ç et al. Prognostic Relevance of Sunitinib Toxicities in Metastatic Renal Cell Cancer. Contemporary Oncology. 2014.

    Source : page de profil sur medicana.com.tr

  30. A30. Tanriverdi O et al. Pretreatment Serum Albumin Level as Prognostic Factor in Stage IIIB NSCLC. Asian Pac J Cancer Prev. 2015;16(14):5971-6.

    Source : page de profil sur medicana.com.tr

  31. A31. Avci N et al. Smoking habits as independent prognostic factor in lung cancer. Clin Respir J. 2015.

    Source : page de profil sur medicana.com.tr

  32. A32. Nayir E et al. Tendency of cancer patients and relatives to use internet for health searches. J BUON. 2016;21(3):714-9.

    Source : page de profil sur medicana.com.tr

  33. A33. Deligonul A et al. HER-4 expression and prognosis in metastatic breast cancer. J BUON. 2016;21(3):564-9.

    Source : page de profil sur medicana.com.tr

  34. A34. Tanriverdi O et al. Mean platelet volume predicting isolated bone metastases in breast cancer. J BUON. 2016;21(4):840-850.

    Source : page de profil sur medicana.com.tr

  35. A35. Avcı N et al. Association and prognostic significance of -1562C/T polymorphism in MMP-9 in gastric cancer. Pathol Oncol Res. 2015;21(4):1243-7.

    Source : page de profil sur medicana.com.tr

  36. A36. Süner A et al. Effectiveness and safety of cabazitaxel chemotherapy in metastatic castration-resistant prostate carcinoma. Eur Rev Med Pharmacol Sci. 2016;20(7):1238-43.

    Source : page de profil sur medicana.com.tr

  37. A37. Artaç M et al. Bevacuzimab effectiveness in obese metastatic colorectal cancer patients. J Gastrointest Cancer. 2018.

    Source : page de profil sur medicana.com.tr

  38. A38. Aksoy A et al. Hormone receptor status and survival in medullary breast cancer patients. Saudi Med J. 2017;38(2):156-162.

    Source : page de profil sur medicana.com.tr